Elham Pourmatroud

Additional information is available at the end of the chapter Elham Pourmatroud

http://dx.doi.org/10.5772/intechopen.70621 Additional information is available at the end of the chapter

Abstract

Most of the time, polycystic ovary syndrome (PCOs) is considered as an obese women disease; lean PCOs patients need to evaluate and treat completely as a neglected subgroup. Androgen excess signs and symptoms, insulin resistance (IR) and its consequences, cardiometabolic risks, and regular exercise must be noted and managed carefully.

Keywords: lean, non-obese, androgen, insulin, PCO
